Overview

Also Known As: Oct-4/rtTA (R26-M2rtTA;Col1a1-tetO-Oct4)

These "Oct-4/rtTA" mutant mice (R26-M2rtTA;Col1a1-tetO-Oct4) may be useful for studies of tumorigenesis and pluripotent stem cells.

Donating Investigator

Rudolf Jaenisch, Whitehead Institute, Massachusetts Institute of Technology

Genetic overview

Genetic Background	Generation

Col1a1^{tm2(tetO-Pou5f1)Jae}

Allele Type	Gene Symbol	Gene Name
Targeted (Inducible, Inserted expressed sequence, RMCE-ready)	Col1a1	collagen, type I, alpha 1

Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}*

Allele Type	Gene Symbol	Gene Name
Targeted (Transactivator)	Gt(ROSA)26Sor	gene trap ROSA 26, Philippe Soriano

View Genetics

Research Applications

Research Tools
Cancer Research
Cell Biology Research

View All Research Applications

Base Price

Starting at:

$2,854.50 Domestic price Cryo Recovery

View Price List

Details

Detailed Description

Mice heterozygous for both targeted mutations (R26-rtTA and Cola1a::tetO-Oct4) are viable and fertile. These "Oct-4/rtTA" mice express rtTA-M2, an optimized form of reverse tetracycline-controlled transactivator (rtTA) protein, in multiple tissues. In the absence of the tetracycline analog doxycycline (dox), Oct4 (Pou5f1) expression from the Col1a1 locus is not detected. Following dox administration, high Oct4 expression is induced in liver, bone marrow, stomach, intestine, and skin, with lower levels in the heart, lungs, kidney, spleen, and thymus; no expression was detected in the brain and testes. Dox-inducd activation of Oct4 results in dysplasia in epithelial tissues. These mutant mice may be useful for studies of tumorigenesis and pluripotent cells.

Development

The R26-M2rtTA targeted mutation has an optimized form of reverse tetracycline controlled transactivator (rtTA-M2) followed by a β-globin intron, polyA signal and PGK-puromycin cassette, all inserted downstream of the Gt(ROSA)26Sor promoter. The targeting vector was electroporated into (C57BL/6 x 129S4Sv/Jae)F1-derived V6.5 embryonic stem (ES) cells. In addition, these ES cells were retargeted to insert an frt-flanked PGK-Neo into the 3' UTR of the Col1a1 locus. Correctly targeted ES cells were selected and the frt-flanked PGK-Neo in the 3' UTR of the Col1a1 locus was replaced by injecting both a "flip-in plasmid" containing a splice acceptor-double polyA sequence and the tetracycline responsive element (TRE or tetO) upstream of the mouse Oct4 (Pou5f1) cDNA sequence, as well as a Flpe-expressing plasmid to facilitate tetO-Oct4 recombination into the 3' UTR of the Col1a1 locus. The resulting ES cells (now targeted with rtTA-M2 in the Gt(ROSA)26Sor locus and tetO-Oct4 in the Col1a1 locus) were injected into B6D2F1 tetraploid blastocysts. Chimeric mice were bred together for many generations prior to arrival at The Jackson Laboratory Repository.

Expression Data

Expressed Gene	Pou5f1, POU domain, class 5, transcription factor 1, mouse, laboratory
Site of Expression	With doxycycline treatment, Pou5f1 expression from the Col1a1 locus is widespread with high levels in skin, intestine and stomach, while lower levels are seen in the heart, spleen, thymus and several other organs.
Expressed Gene	rtTA, reverse tetracycline-controlled transactivator, E. coli
Site of Expression	Expresses an optimized rtTA protein (rtTA-M2). Inducible target gene expression is detected in liver, bone marrow, stomach, intestine, and skin, with lower levels in the heart, lungs, kidney, spleen, and thymus; no expression is detected in the brain and testes.

Control Suggestions

Approximate Controls

Additional Information

Considerations for Choosing Controls

Selected References

Hochedlinger K; Yamada Y; Beard C; Jaenisch R. 2005. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121(3):465-77PubMed: 15882627 MGI: J:98920

View All References

Genetics

Col1a1^{tm2(tetO-Pou5f1)Jae}

Allele Symbol: Col1a1^{tm2(tetO-Pou5f1)Jae}

Allele Name	targeted mutation 2, Rudolf Jaenisch
Allele Type	Targeted (Inducible, Inserted expressed sequence, RMCE-ready)
Allele Synonym(s)	Col1a1^{tm2(tetO-Pou5f1)Jae}; targeted mutation 2, Rudolf Jaenisch
Gene Symbol and Name	Col1a1, collagen, type I, alpha 1
Gene Synonym(s)	Cola1; Cola1; COLIA1; Mov-13; Col1a-1; Cola-1; Mov-13; Moloney leukemia virus 13; OI4; Col1a-1; Cola-1; OI3; EDSC; OI1; OI2; EDSARTH1
Promoter	tetO, tet operator,
Expressed Gene	Pou5f1, POU domain, class 5, transcription factor 1, mouse, laboratory
Site of Expression	With doxycycline treatment, Pou5f1 expression from the Col1a1 locus is widespread with high levels in skin, intestine and stomach, while lower levels are seen in the heart, spleen, thymus and several other organs.
Strain of Origin	(C57BL/6 x 129S4/SvJae)F1
Chromosome	11
Molecular Note	ES cells containing the Gt(ROSA)26Sor^{tm1(rtTA2S-M2)Jae} mutation were retargeted. Cells were injected with a "flip-in plasmid" containing a tetracycline responsive element (TRE or tetO) and mouse Oct4 (Pou5f1) cDNA sequence (and a Flpe-recombinase plasmid to facilitate tetO-Oct4 integration into the 3' UTR region of Col1a1). With doxycycline treatment, Pou5f1 expression from the Col1a1 locus is widespread with high levels in skin, intestine and stomach, while lower levels are seen in the heart, spleen, thymus and several other organs. No expression is seen in the brain or testes.

Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}*

Allele Symbol: Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}*

Allele Name	targeted mutation 1, Rudolf Jaenisch
Allele Type	Targeted (Transactivator)
Allele Synonym(s)	Gt(ROSA)26Sor^{tm1(rtTA*M2)Jae}; targeted mutation 1, Rudolf Jaenisch
Gene Symbol and Name	Gt(ROSA)26Sor, gene trap ROSA 26, Philippe Soriano
Gene Synonym(s)	beta geo; ROSA26; R26; Gtrgeo26; Gtrosa26; Gtrgeo26; Gtrosa26; AV258896; expressed sequence AV258896; gene trap ROSA 26; gene trap ROSA b-geo 26; SETD5-AS1; Thumpd3as1
Expressed Gene	rtTA, reverse tetracycline-controlled transactivator, E. coli
Site of Expression	Expresses an optimized rtTA protein (rtTA-M2). Inducible target gene expression is detected in liver, bone marrow, stomach, intestine, and skin, with lower levels in the heart, lungs, kidney, spleen, and thymus; no expression is detected in the brain and testes.
Strain of Origin	(C57BL/6 x 129S4/SvJae)F1
Chromosome	6
General Note	This mutation was created during the generation of mutant ES cell line KH2, which also contains a frt docking site downstream of the endogenous Col1a1 locus on Chr 11 (Col1a1). The two mutations have subsequently been bred apart.
Molecular Note	An optimized form of reverse tetracycline controlled transactivator (rtTA-M2) was inserted downstream of the Gt(ROSA)26Sor promoter and was followed by a PGK-puro selection cassette. This mutant form of rtTA termed M2 has five amino acid substitutions in the tetR moiety of tTA: S12G, E19G, A56P, D148E and H179R. This mutated form of transactivator protein has increased doxycycline sensitivity. Mice have widespread expression of the rtTA-M2 protein.
Mutations Made By	Rudolf Jaenisch, Whitehead Institute, Massachusetts Institute of Technology

Disease/Phenotype

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Research Tools
- Tet Expression Systems
  - tTA/rtTA Expressing Strains
  - tTA/rtTA Responsive Strains
- Genetics Research
  - Mutagenesis and Transgenesis
  - Mutagenesis and Transgenesis: transcriptional activation
  - Mutagenesis and Transgenesis: Tetop Tet System
- Cancer Research
  - Tetop Tet System
Cancer Research
- Other
Cell Biology Research
- Transcriptional Regulation

Mammalian Phenotype Terms by Genotype

The following phenotype relates to a compound genotype created using this strain

Genotype: Col1a1^{tm2(tetO-Pou5f1)Jae}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺
involves: 129S4/SvJae C57BL/6

behavior/neurological phenotype

lethargy
- animals become lethargic with doxycycline treatment within 3-5 days

endocrine/exocrine gland phenotype

abnormal intermediate gastric gland morphology
- hyperplastic fundic glands are seen in doxycycline treated mice

thymus atrophy
- atrophy and absence of CD4, CD8 double positive cells in doxycycline treated mice

hematopoietic system phenotype

spleen atrophy
- in doxycycline treated mice

thymus atrophy
- atrophy and absence of CD4, CD8 double positive cells in doxycycline treated mice

cellular phenotype

abnormal cell proliferation
- abnormal cell proliferation is observed in several organs after 2 days of Oct4-induction
- Normal - however, complete reversion is seen with withdrawal of doxycycline treatment

homeostasis/metabolism phenotype

dehydration
- after 3-5 days of doxycycline treatment, animals display severe dehydration

immune system phenotype

spleen atrophy
- in doxycycline treated mice

thymus atrophy
- atrophy and absence of CD4, CD8 double positive cells in doxycycline treated mice

integument phenotype

abnormal epidermal layer morphology
- after 5-10 days of doxycycline treatment, mice show mild to moderate epidermal dysplasia with a decrease in differentiation in dysplastic cells

abnormal hair follicle morphology
- increased numbers of immature cells in the hair follicles of the skin are seen after 5-10 days of doxycycline

increased skin tumor incidence
- in doxycycline treated mice, tumors originating from the outer-root-sheath progenitors and invading the subcutaneous layer are seen

mortality/aging

premature death
- Normal - however, if doxycycline treatment is stopped after 5 days mice completely recover
- mice with doxycycline-induced ectopic Oct4 expression become morbid after 3-5 days of treatment and usually die after 5-10 days of treatment

neoplasm

increased skin tumor incidence
- in doxycycline treated mice, tumors originating from the outer-root-sheath progenitors and invading the subcutaneous layer are seen

digestive/alimentary phenotype

abnormal forestomach morphology
- in doxycycline treated mice, cells in the forestomach show a marked atypia and increased mitotic activity

abnormal intermediate gastric gland morphology
- hyperplastic fundic glands are seen in doxycycline treated mice

abnormal intestinal epithelium morphology
- after doxycline treatment, dysplastic cells are found in the entire epithelium; cells have structural and cytological dysplasia which mimics adenocarcinoma

abnormal small intestine morphology
- after 5 days of doxycycline treatment, proliferative zone expands; postmitotic, differentiated cells lining the villus are replaced
- the proximal part of the small intestine is most severely affected by doxycycline treatment with abnormal cells often almost obstructing the lumen
- upon cessation of treatment, cells migrate to final destinations and differentiate
- Normal - upon cessation of treatment, cells migrate to final destinations and differentiate resulting in restoration of normal morphology

abnormal stomach epithelium morphology
- in doxycycline treated mice, forestomach epithelium is thickened and stomach shows lack of differentiation into granular and cornified cell layers compared to control mice
- the thickened epithelium consists of atypical cells with enlarged nuclei and prominent nucleoli

abnormal stomach glandular epithelium morphology
- after doxycycline treatment, mice display severe dysplasia and increased proliferation

abnormal stomach mucosa morphology
- pyloric mucosa contains lesions resembling high grade-dysplasia in doxycycline treated mice

stomach epithelial hyperplasia
- cells show atypia and increased mitotic activity throughout the squamous epithelial layer in doxycycline treated mice

References

Hochedlinger K; Yamada Y; Beard C; Jaenisch R. 2005. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121(3):465-77PubMed: 15882627 MGI: J:98920

Additional - Col1a1^{tm2(tetO-Pou5f1)Jae} related

Additional - Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}* related

Technical Support

Contact Technical Support

Genotyping Protocols
- Probe:Gt(rosa)26sor^Tm1SorProbe
- Separated MCA:Gt(ROSA)26Sor
- Separated MCA:Gt(ROSA)26Sor^tm1Sor
- Standard PCR:Col1a1 3'UTR mutation 2
- Standard PCR:Gt(ROSA)26Sor
- Standard PCR:Gt(ROSA)26Sor^tm1Sor
- Genotyping resources and troubleshooting
Breeding Considerations

When maintaining a live colony, mice that are heterozygous or homozygous for Gt(ROSA)26Sor^{tm1(rtTA*M2)Jae} and heterozygous for Col1a1^{tm2(tetO-Pou5f1)Jae} may be bred together.
- Additional Breeding and Husbandry Support
Citation
When using the Oct-4/rtTA (R26-M2rtTA;Col1a1-tetO-Oct4) mouse strain in a publication, please cite the originating article(s) and include JAX stock #006911 in your Materials and Methods section.

Animal Health Reports

Facility Barrier Level Descriptions

Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200

Pricing & Availability

Cryo Recovery

Domestic
International

Live Mouse

Age

Genotype

Price

weeks

Cryorecovery - Pricing

Service	Genotype	Price
	Heterozygous for Gt(ROSA)26Sor<tm1(rtTA*M2)Jae>, Heterozygous or wildtype for Col1a1<tm2(tetO-Pou5f1)Jae>

We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.

Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.

Terms Of Use

Terms of Use

General Terms and Conditions

Questions about Terms of Use

Additional Use Restrictions Apply

Use of MICE by companies or for-profit entities requires a license prior to shipping.

Licensing Information

Phone: 207-288-6470

Email: TechTran@jax.org

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

Credit for PRODUCTS or SERVICES

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.

Animal Care and Use for SERVICES

Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.

Also Known As: Oct-4/rtTA (R26-M2rtTA;Col1a1-tetO-Oct4)

Donating Investigator

Genetic overview

Research Applications

Base Price

Detailed Description

Development

Expression Data

Control Suggestions

Approximate Controls

Additional Information

Selected References

Col1a1tm2(tetO-Pou5f1)Jae

Allele Symbol: Col1a1tm2(tetO-Pou5f1)Jae

Gt(ROSA)26Sortm1(rtTA*M2)Jae

Allele Symbol: Gt(ROSA)26Sortm1(rtTA*M2)Jae

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Mammalian Phenotype Terms by Genotype

Genotype: Col1a1tm2(tetO-Pou5f1)Jae/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+involves: 129S4/SvJae * C57BL/6

behavior/neurological phenotype

endocrine/exocrine gland phenotype

hematopoietic system phenotype

cellular phenotype

homeostasis/metabolism phenotype

immune system phenotype

integument phenotype

mortality/aging

neoplasm

digestive/alimentary phenotype

References

Additional - Col1a1tm2(tetO-Pou5f1)Jae related

Additional - Gt(ROSA)26Sortm1(rtTA*M2)Jae related

Genotyping Protocols

Breeding Considerations

Citation

Animal Health Reports

Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200

Live Mouse

Cryorecovery - Pricing

Payment Terms and Conditions

The Jackson Laboratory's Genotype Promise

Terms of Use

Additional Use Restrictions Apply

Licensing Information

JAX® Mice, Products & Services Conditions of Use

No Warranty

Credit for PRODUCTS or SERVICES

Animal Care and Use for SERVICES

No Liability

Col1a1^{tm2(tetO-Pou5f1)Jae}

Allele Symbol: Col1a1^{tm2(tetO-Pou5f1)Jae}

Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}*

Allele Symbol: Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}*

Genotype: Col1a1^{tm2(tetO-Pou5f1)Jae}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺
involves: 129S4/SvJae C57BL/6

Additional - Col1a1^{tm2(tetO-Pou5f1)Jae} related

Additional - Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}* related